Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

5d ago, source:

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions ...

Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know

5d ago, source:

Analysts have recently evaluated Collegium Pharmaceutical and provided 12-month price targets. The average target is $39.75, accompanied by a high estimate of $40.00 and a low estimate of $39.00. This ...

Commit To Purchase Collegium Pharmaceutical At $17.50, Earn 6.7% Annualized Using Options

4d ago, source: Nasdaq

Investors eyeing a purchase of Collegium Pharmaceutical Inc (Symbol: COLL) stock, but cautious about paying the going market price of $35.97/share, might benefit from considering selling puts ...

Collegium Pharmaceutical

5d ago, source: Forbes

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

13d ago, source:

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving ...

Collegium Pharmaceutical: Q4 Earnings Snapshot

1mon ago, source: SFGate

STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported fourth-quarter profit of $31.9 million. On a per-share basis, the Stoughton ...

Q4 2023 Collegium Pharmaceutical Inc Earnings Call

1mon ago, source: Yahoo Finance

Q4 2023 Collegium Pharmaceutical Inc Earnings Call Q4 2023 Collegium Pharmaceutical Inc Earnings Call HOME MAIL NEWS FINANCE SPORT CELEBRITY STYLE WEATHER MORE... Yahoo Finance Sign in Mail Sign in to ...

Collegium Pharmaceutical Inc.

5d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Collegium Pharmaceutical Inc COLL

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...